Global Stem Cell Assay Market Size, Share, Forecast Report, 2020-2027

Stem cells have a remarkable potential to develop into different types of cells and are involved in the internal repair system of the body. Stem cell assays are the techniques for analyzing the living cells on the parameters of shape, size, besides others with the aim to measure biochemical and cellular functioning of the cells. Such properties make the stem cell assays to be extensively utilized in industrial practices of drug development. Growing biotechnology sector and increasing global burden of diseases like cancer, diabetes, and others are estimated to be the major drivers for the market growth during the forecast period. According to the World Health Organization in 2017, the number of patients suffering from diabetes was estimated to be about 422 million in 2014. Moreover, WHO projected that by 2030, diabetes would be the seventh leading cause of death across the globe. Additionally, growing healthcare expenditure and rising government support boosts the market growth during the forecast period. However, factors such as stringent government policies, high procedural cost followed by lack of awareness and skilled forces will restrain the market growth during the projected period, 2017-2023.
Segmentation

The global stem cell assay market is segmented on the basis of product, technology, assay, application, and end-user.

On the basis of the product, the market is categorized into microelectrode arrays, flow cytometer, cell imaging systems, automated cell counter, kits, and others. The kits segment is sub-segmented into mesenchymal stem cell kits, induced pluripotent stem cell kits, umbilical cord stem cells, and others. On the basis of the technology, the market is segmented into microfabricated assisted technology microfluidics-based cell trap technologies, and others. On the basis of the assay, the market is segmented into cell viability & toxicity assays, cell identification assays, cell proliferation assays, cell apoptosis assays, and others. On the basis of the application, the market is segmented into the orthopedic & musculoskeletal spine, dermatology, cardiovascular, central nervous system, and others. On the basis of the end user, the market is segmented into biotechnology industries, research organizations, academic institutes, and others.

Key players for global stem cell assay market

GE Healthcare (U.K.), Promega Corporation (U.S.), Thermo Fisher Scientific (U.S.), Merck KGaA (Germany), Cell Biolabs, Inc. (U.S.), Hemogenix (U.S.), STEMCELL Technologies Inc. (CA), Bio-Rad Laboratories, Inc. (U.S.), Bio-Techne Corporation (U.S.), and Cellular Dynamics International Inc. (U.S.), and others.